ATE135740T1 - Artifizielles gen, das für humane serumalbumine kodiert, seine verwendung und verfahren zu seiner herstellung - Google Patents

Artifizielles gen, das für humane serumalbumine kodiert, seine verwendung und verfahren zu seiner herstellung

Info

Publication number
ATE135740T1
ATE135740T1 AT88850299T AT88850299T ATE135740T1 AT E135740 T1 ATE135740 T1 AT E135740T1 AT 88850299 T AT88850299 T AT 88850299T AT 88850299 T AT88850299 T AT 88850299T AT E135740 T1 ATE135740 T1 AT E135740T1
Authority
AT
Austria
Prior art keywords
human serum
serum albumin
disclosed
production
gene coding
Prior art date
Application number
AT88850299T
Other languages
English (en)
Inventor
Bertil Aberg
Andras Simoncsits
Miklos Kalman
Imre Cserpan
Gyoergy Bajszar
Original Assignee
Skandigen Ab
Mta Szegedi Biolog Koezponti
Vepex Contractor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20369553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE135740(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Skandigen Ab, Mta Szegedi Biolog Koezponti, Vepex Contractor Ltd filed Critical Skandigen Ab
Application granted granted Critical
Publication of ATE135740T1 publication Critical patent/ATE135740T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
AT88850299T 1987-09-14 1988-09-13 Artifizielles gen, das für humane serumalbumine kodiert, seine verwendung und verfahren zu seiner herstellung ATE135740T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8703539A SE459586B (sv) 1987-09-14 1987-09-14 Strukturgen som kodar foer autentiskt humant serum albumin och foerfarande foer dess framstaellning

Publications (1)

Publication Number Publication Date
ATE135740T1 true ATE135740T1 (de) 1996-04-15

Family

ID=20369553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88850299T ATE135740T1 (de) 1987-09-14 1988-09-13 Artifizielles gen, das für humane serumalbumine kodiert, seine verwendung und verfahren zu seiner herstellung

Country Status (12)

Country Link
EP (1) EP0308381B1 (de)
JP (1) JP2865683B2 (de)
AT (1) ATE135740T1 (de)
CA (1) CA1340650C (de)
DD (1) DD282473A5 (de)
DE (1) DE3855122T2 (de)
DK (1) DK163937C (de)
FI (1) FI901219A0 (de)
IL (1) IL87748A (de)
PL (1) PL274669A1 (de)
SE (1) SE459586B (de)
WO (1) WO1989002467A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2791418B2 (ja) * 1987-12-02 1998-08-27 株式会社ミドリ十字 異種蛋白質の製造方法、組換えｄｎａ、形質転換体
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
US5759802A (en) * 1988-10-26 1998-06-02 Tonen Corporation Production of human serum alubumin A
US6406697B1 (en) 1989-02-23 2002-06-18 Genentech, Inc. Hybrid immunoglobulins
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
GB8909916D0 (en) * 1989-04-29 1989-06-14 Delta Biotechnology Ltd Polypeptides
ATE92107T1 (de) * 1989-04-29 1993-08-15 Delta Biotechnology Ltd N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
CA2017176A1 (en) * 1989-05-22 1990-11-22 Yoshitomi Pharmaceutical Industries Ltd. Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
JPH0669365B2 (ja) * 1989-05-22 1994-09-07 株式会社ミドリ十字 アルブミン遺伝子を含むプラスミド、形質転換体、形質転換体の製造方法、アルブミンの製造方法
NL8901932A (nl) * 1989-07-26 1991-02-18 Mogen Int Produktie van heterologe eiwitten in planten of plantecellen.
GB8923521D0 (en) * 1989-10-18 1989-12-06 Delta Biotechnology Ltd Yeast promoter
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
JPH07308199A (ja) * 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
US5514551A (en) * 1994-10-14 1996-05-07 Gen-Probe Incorporated Compositions for the detection of Chlamydia trachomatis
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
CA2405709A1 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
EP0079739A3 (de) * 1981-11-12 1984-08-08 The Upjohn Company Auf Albumin basierende Nukleotiden, ihre Replikation und Verwendung und Plasmide zur Verwendung darin
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
JPS62500103A (ja) * 1984-08-29 1987-01-16 チロン　コ−ポレイシヨン ヒト結合組織アクチベ−タ−及び関連ペプチドの発現
GB8427006D0 (en) * 1984-10-25 1984-11-28 Iq Bio Ltd Determination of chlamydia trachomatis
HU194308B (en) * 1984-11-23 1988-01-28 Mta Szbk Genetikai Intezete Process for preparing oligo- and polydeoxyribonucleotides
AU5890286A (en) * 1985-06-17 1986-12-24 Genex Corp. Cloned human serum albumin gene
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins

Also Published As

Publication number Publication date
DD282473A5 (de) 1990-09-12
IL87748A0 (en) 1989-02-28
DK163937B (da) 1992-04-21
DE3855122D1 (de) 1996-04-25
DK64990D0 (da) 1990-03-13
JPH03501323A (ja) 1991-03-28
PL274669A1 (en) 1989-08-21
CA1340650C (en) 1999-07-13
SE8703539D0 (sv) 1987-09-14
WO1989002467A1 (en) 1989-03-23
SE459586B (sv) 1989-07-17
SE8703539L (sv) 1989-03-15
DK64990A (da) 1990-05-14
IL87748A (en) 1993-06-10
DE3855122T2 (de) 1996-10-17
JP2865683B2 (ja) 1999-03-08
EP0308381A1 (de) 1989-03-22
DK163937C (da) 1992-09-14
FI901219A0 (fi) 1990-03-12
EP0308381B1 (de) 1996-03-20

Similar Documents

Publication Publication Date Title
ATE135740T1 (de) Artifizielles gen, das für humane serumalbumine kodiert, seine verwendung und verfahren zu seiner herstellung
DE59610898D1 (de) Verfahren zur herstellung von erythropoietin frei von tierischen proteinen
ATA42192A (de) Verfahren zur herstellung von neuen organischen säuren bzw. säurechloriden
ATE152124T1 (de) Wachstumsfaktor aus parenchymalen lebenszellen, dafür kodierendes gen, verfahren zur herstellung dieses faktors und transformanten
DE3587422T2 (de) Für ein hirudinähnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
DE3669175D1 (de) Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung.
ATE124454T1 (de) Gentechnische herstellung von faktor xiiia.
EP0922768A3 (de) Onkogen- oder virusgesteuerte Expressionssysteme
DE3854420T2 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
ATE100495T1 (de) Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine.
EP0048455A3 (de) Synthetisches DNS und Verfahren dafür
SE8605621D0 (sv) Heteromultimeric proteins and their manufacture
EP0284898A3 (de) Hinge-Peptid, Verfahren zu seiner Herstellung und seine Verwendung zur Herstellung synthetischer Immunogene
DE3484216D1 (de) Biosynthetische 2,5-diketogluconsaeurereduktase, verfahren, rekombinante zellen und expressionsvektoren fuer ihre herstellung und ihre verwendung zur bereitung von 2-keto-l-gulonsaeure.
DE69530647D1 (de) Für biosynthetische Insulinvorstufen kodierende DNA-Sequenzen und Verfahren zur Herstellung von Insulin
DE3787044T2 (de) Transformant einer tierischen Zelle, Verfahren zur Herstellung des Transformanten und dessen Verwendung zur Präparation eines gewünschten Fremdgenproduktes.
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
ATE117374T1 (de) Hühner-beta-actin-promoter und menschliches faktor viii-c-gen enthaltende plasmide, transformanten und verfahren zur herstellung des menschlichen faktors viii-c.
ATE91717T1 (de) Verfahren zur herstellung von proteinen in loeslicher form.
AT360650B (de) Verfahren zur herstellung von neuen 7alpha- methoxy-7beta-(1,3-dithiaethan-2-carboxamido) cephalosporansaeurederivaten
ATA186592A (de) Nukleotidsequenz, die für den transforming growth faktor-beta2 kodiert, transforming growth faktor-beta2 sowie verfahren und zellen zur herstellung desselben
ATA818879A (de) Verfahren zur herstellung von neuen, stabilisierten azulminsaeuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties